The Fourth International Consultation on Incontinence recently redefined the signs, symptoms, urodynamic observations and conditions associated with lower urinary tract symptoms and urodynamic ...
PHIOGEN, a biotech company developing live biotherapeutic products (LBPs) for drug-resistant and recurrent bacterial infections, is collaborating with patient research and advocacy organization Live ...
1. Current NAV: The Current Net Asset Value of the UTI Large Cap Fund - Regular Plan as of Nov 21, 2024 is Rs 257.60 for Growth option of its Regular plan. 2. Returns: Its trailing returns over ...
UTI Asset Management Company Ltd., incorporated in the year 2002, is a Small Cap company (having a market cap of Rs 16,594.93 Crore) operating in Financial Services sector. UTI Asset Management ...
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on ...
Fund manager updated portfolio more frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for shorter duration than peers) ...
US and MCUG for all children aged <2 years. 99m Tc–DMSA scan in high-grade reflux [3] Urinary tract infection (UTI) is the most common serious bacterial infection in childhood, and its ...